Mass General Brigham researchers used long-term data and a blood test for the biomarker pTau217 to identify the earliest signs of Alzheimer’s disease in cognitively healthy adults.
Plasma pTau217 may detect initial buildup of AD-related brain changes before they can be detected by current ‘gold standard’ ...
Can a blood test predict Alzheimer’s? New research shows the pTau217 biomarker detects amyloid accumulation and cognitive ...
Boston scientists say a routine blood draw might spot the earliest changes of Alzheimer’s long before the brain lights up on ...
A study by investigators at Mass General Brigham has found that a blood test of plasma phosphorylated tau 217 (pTau217), an ...
Going on antidepressants can give many people their life back, but for some there is a catch. About 25% to 80% of people who take antidepressants experience sexual side effects to some degree during ...
A special MRI technique that detects iron levels in different regions of the brain can predict the onset of mild cognitive impairment and cognitive decline in cognitively unimpaired older adults, ...
A new study shows that a blood test measuring plasma phosphorylated tau 217 (pTau217) can identify Alzheimer’s disease risk years before brain scans detect changes. Researchers found elevated pTau217 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results